BrainScope Awarded Montgomery County Emerging Business of the Year

  BrainScope Awarded Montgomery County Emerging Business of the Year

    Company Recognized For Its Work on Traumatic Brain Injury / Concussion

Business Wire

BETHESDA, Md. -- December 06, 2012

BrainScope^® Company, Inc. announced today that it received the Verl Zanders
Emerging Business of the Year Award by the Montgomery County Chamber of
Commerce (MCCC) last evening at the 2012 MCCC Business Awards Dinner &
Reception. The event was attended by over 700 business and government leaders.
Among the seven awards presented during the evening were esteemed recipients
such as J.W. Marriott, Jr. (Emeritus Business Leader), Booz Allen Hamilton
(Prime Partner of the Year), and Lockheed Martin (Corporate Achievement).

“We are greatly honored and humbled to receive this award. We would not be
here without the significant support of our partner, the U.S. Department of
Defense,” stated Michael Singer, President and CEO of BrainScope. “The men and
women who risk their lives every day for our country are our inspiration, and
we owe it to them to continue our work in developing a device to assess
traumatic brain injury and concussion at the point of care.”

“Over the years, the Montgomery County Chamber of Commerce has recognized
remarkable companies that have grown to become leaders in their fields,”
commented Georgette “Gigi” Godwin, President and CEO of MCCC. “Past winners of
the Verl Zanders Emerging Business of the Year Award have included Qiagen,
MedImmune and Honest Tea. The selection committee was impressed by
BrainScope’s progress and its prospects for helping soldiers, athletes and
individuals suffering from concussions and other brain injuries.”

In the last year, BrainScope has been awarded research and development
contracts valued in excess of $10 million by the U.S. Department of Defense.
In May 2011 BrainScope reached concurrence with the U.S. Food and Drug
Administration (FDA) on the key study design elements for clinical validation
of the Ahead^® M-100 medical device.

Since 2010, results from clinical studies utilizing BrainScope’s technology
have been published in leading peer-reviewed neurology and emergency medicine
journals such as Brain Injury, The Journal of Head Trauma Rehabilitation and
The American Journal of Emergency Medicine.

About BrainScope^®

Backed by Revolution (created by AOL co-founder Steve Case), Shaman Ventures,
ZG Ventures, Maryland Venture Fund and Brain Trust Accelerator Fund,
BrainScope is a medical neurotechnology company that is developing a new
generation of hand-held, easy-to-use, non-invasive instruments designed to aid
medical professionals in rapidly and objectively assessing brain function.
BrainScope devices in development are based on a proprietary technology
platform, which integrates databases of brainwave recordings with advanced
digital signal processing, sophisticated algorithms, miniaturized hardware and
disposable headset sensors. The company’s initial focus is on traumatic brain
injury and its milder presentation, commonly referred to as "concussion".
BrainScope's unique devices are being created to meet a long-standing clinical
need for improved early identification, staging and triage of head injured
patients. BrainScope devices under development for assessment of
traumatically-induced head injury and concussion are for investigational use
only and have not been submitted to FDA for premarket review. For more
information, please visit www.brainscope.com.

Contact:

BrainScope
Laurie Silver, 240-752-7680
laurie.silver@brainscope.com
 
Press spacebar to pause and continue. Press esc to stop.